Insulet Corporation (PODD)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
US Omnipod Revenue	2.12B	1.92B	1.51B
International Omnipod Revenue	910.80M	754.30M	523.40M
Total Omnipod Revenue	3.04B	2.67B	2.03B
Drug Delivery Revenue	18.10M	34.10M	38.90M
Revenue (Other)	200.00K	-	-
Revenue (Total)	3.05B	2.71B	2.07B

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
United States Revenue	2.14B	1.95B	1.55B
International Revenue	910.80M	754.30M	523.40M
Revenue (Other)	100.00K	-	-
Revenue (Total)	3.05B	2.71B	2.07B

Data Source: Fiscal.ai Last updated: Aug 5, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 14, 2026

Data Sources Report a data error